Richard Larson to Angiogenesis Inhibitors
This is a "connection" page, showing publications Richard Larson has written about Angiogenesis Inhibitors.
Connection Strength
0.297
-
Myelodysplasia: when to treat and how. Best Pract Res Clin Haematol. 2006; 19(2):293-300.
Score: 0.203
-
Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance). Br J Clin Pharmacol. 2014 Nov; 78(5):1005-13.
Score: 0.094